Skip to main content

Advertisement

Table 3 Differences between serum FA-ceramide (CER) (nmol/ml) concentrations in study group and reference group

From: Increased serum concentration of ceramides in obese children with nonalcoholic fatty liver disease

Ceramide (FA) Study group M (Q1-Q3) Reference group M (Q1-Q3) p value
CER myristic (C14:0) 2.1 (1.4–4.3) 0.9 (0.7–1.2) < 0.001
CER palmitic (C16:0) 8.6 (6.7–10.4) 5.2 (4.8–6.8) < 0.001
CER palmitoleic (C16:1) 1.0 (0.8–1.3) 0.6 (0.5–0.8) < 0.001
CER stearic (C18:0) 5.6 (4.5–7.6) 4.0 (3.6–4.5) < 0.005
CER oleic (C18:1) 2.8 (2.4–3.6) 2.1 (1.9–2.8) < 0.005
CER linoleic (C18:2) 0.3 (0.0–1.0) 0.2 (0.0–0.7) ns
CER arachidic (C20:0) 0.5 (0.4–0.6) 0.4 (0.4–0.5) ns
CER linolenic (C18:3) 0.3 (0.2–0.3) 0.2 (0.2–0.3) ns
CER behenic (C22:0) 1.5 (1.3–1.7) 1.3 (1.1–1.4) < 0.01
CER arachidonic (C20:4) 0.5 (0.4–0.7) 0.5 (0.4–0.7) ns
CER lignoceric (C24:0) 3.3 (2.8–4.1) 3.0 (2.6–3.3) < 0.05
CER eicosapentaenoic (C20:5) 0.8 (0.7–0.9) 0.8 (0.7–0.9) ns
CER nervinic (C24:1) 2.3 (2.0–2.6) 2.0 (1.9–2.2) ns
CER docosahexaenoic (C22:6) 0.7 (0.6–0.9) 0.7 (0.6–0.8) ns